ClinicalTrials.Veeva

Menu

DIETary Intake, Death and Hospitalization in Adult With End-stage Kidney Disease Treated With HemoDialysis (DIET-HD) Study

G

Giovanni Strippoli

Status

Completed

Conditions

Diet Habit
End Stage Renal Disease

Treatments

Other: dietary intake of omega-3 and omega-6 polyunsaturated fatty acids

Study type

Observational

Funder types

Other

Identifiers

NCT03125265
DIET-HD study

Details and patient eligibility

About

The DIETary intake, death and hospitalisation in adults with end-stage kidney disease treated with HaemoDialysis (DIET-HD) study is a multinational prospective cohort study designed to evaluate the association between nutrition and dietary patterns and health outcomes in prevalent adult haemodialysis patients in Europe and South America.

Enrollment

9,757 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • End-stage kidney disease
  • Long-term haemodialysis for at least the previous 90 days
  • 18 years or older
  • Treating team agrees to the patient's involvement in the study
  • Participant willing to provide written and informed consent.-

Exclusion criteria

  • significant neurocognitive disability or medical comorbidity that would preclude them from understanding the dietary questionnaire even if assisted
  • a life expectancy less than 6 months according to their treating physician
  • planned kidney transplantation within 6 months of baseline

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems